Clinical Trials Related to Bristol-Myers Squibb

Related studies linked through entity extraction aliases.

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

Status: COMPLETED
Phase: PHASE3

Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen

Status: NO_LONGER_AVAILABLE
Phase: N/A

Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors

Status: TERMINATED
Phase: PHASE1/PHASE2

Study of Venous Endothelial Cells in Rheumatoid Arthritis

Status: COMPLETED
Phase: N/A

Apixaban for the Acute Treatment of Venous Thromboembolism in Children

Status: COMPLETED
Phase: PHASE4

Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Status: COMPLETED
Phase: PHASE1/PHASE2

Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients

Status: COMPLETED
Phase: N/A

Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes

Status: COMPLETED
Phase: PHASE3

A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis

Status: UNKNOWN
Phase: PHASE3

Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients

Status: COMPLETED
Phase: PHASE1

Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study

Status: WITHDRAWN
Phase: PHASE2

Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Status: COMPLETED
Phase: N/A

CV004-007 Thrombosis Chamber Study

Status: COMPLETED
Phase: PHASE1

Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients

Status: UNKNOWN
Phase: PHASE1

NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma

Status: COMPLETED
Phase: PHASE2

Abatacept for SLE Arthritis (IM101-330)

Status: TERMINATED
Phase: PHASE1/PHASE2

Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma

Status: COMPLETED
Phase: PHASE2

Cost of Monitoring Patients Treated With Vitamin K Antagonists in Spain

Status: COMPLETED
Phase: N/A

Apixaban for Treatment of Embolic Stroke of Undetermined Source

Status: COMPLETED
Phase: PHASE3